Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Editorial: US Cancer Statistics of Survival: Achievements, Challenges, and Future Directions.

Literature DB >> 28954287

Editorial: US Cancer Statistics of Survival: Achievements, Challenges, and Future Directions.

Shahinaz M Gadalla¹, Brigitte C Widemann¹.

Abstract

Mesh：

Year: 2017 PMID： 28954287 PMCID： PMC6059201 DOI： 10.1093/jnci/djx070

Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506

× No keyword cloud information.

19 in total

1. Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988-1994 Through 2013-2014.

Authors: Cynthia L Ogden; Margaret D Carroll; Hannah G Lawman; Cheryl D Fryar; Deanna Kruszon-Moran; Brian K Kit; Katherine M Flegal
Journal: JAMA Date: 2016-06-07 Impact factor: 56.272

2. The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.

Authors: Joseph M Unger; Elise Cook; Eric Tai; Archie Bleyer
Journal: Am Soc Clin Oncol Educ Book Date: 2016

3. Prevalence of obesity in the United States.

Authors: Cynthia L Ogden; Margaret D Carroll; Katherine M Flegal
Journal: JAMA Date: 2014-07 Impact factor: 56.272

Review 4. Improving the outcome for children with cancer: Development of targeted new agents.

Authors: Peter C Adamson
Journal: CA Cancer J Clin Date: 2015-03-09 Impact factor: 508.702

5. Body Fatness and Cancer--Viewpoint of the IARC Working Group.

Authors: Béatrice Lauby-Secretan; Chiara Scoccianti; Dana Loomis; Yann Grosse; Franca Bianchini; Kurt Straif
Journal: N Engl J Med Date: 2016-08-25 Impact factor: 91.245

6. First-line crizotinib versus chemotherapy in ALK-positive lung cancer.

Authors: Benjamin J Solomon; Tony Mok; Dong-Wan Kim; Yi-Long Wu; Kazuhiko Nakagawa; Tarek Mekhail; Enriqueta Felip; Federico Cappuzzo; Jolanda Paolini; Tiziana Usari; Shrividya Iyer; Arlene Reisman; Keith D Wilner; Jennifer Tursi; Fiona Blackhall
Journal: N Engl J Med Date: 2014-12-04 Impact factor: 91.245

7. Influence of NCI cancer center attendance on mortality in lung, breast, colorectal, and prostate cancer patients.

Authors: Tracy Onega; Eric J Duell; Xun Shi; Eugene Demidenko; Daniel Gottlieb; David C Goodman
Journal: Med Care Res Rev Date: 2009-05-19 Impact factor: 3.929

8. Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Authors: Nita L Seibel; Peter G Steinherz; Harland N Sather; James B Nachman; Cynthia Delaat; Lawrence J Ettinger; David R Freyer; Leonard A Mattano; Caroline A Hastings; Charles M Rubin; Kathy Bertolone; Janet L Franklin; Nyla A Heerema; Torrey L Mitchell; Allan F Pyesmany; Mei K La; Cheryl Edens; Paul S Gaynon
Journal: Blood Date: 2007-11-26 Impact factor: 22.113

9. Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.

Authors: Kirk R Schultz; W Paul Bowman; Alexander Aledo; William B Slayton; Harland Sather; Meenakshi Devidas; Chenguang Wang; Stella M Davies; Paul S Gaynon; Michael Trigg; Robert Rutledge; Laura Burden; Dean Jorstad; Andrew Carroll; Nyla A Heerema; Naomi Winick; Michael J Borowitz; Stephen P Hunger; William L Carroll; Bruce Camitta
Journal: J Clin Oncol Date: 2009-10-05 Impact factor: 44.544

10. Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial.

Authors: Alice T Shaw; Leena Gandhi; Shirish Gadgeel; Gregory J Riely; Jeremy Cetnar; Howard West; D Ross Camidge; Mark A Socinski; Alberto Chiappori; Tarek Mekhail; Bo H Chao; Hossein Borghaei; Kathryn A Gold; Ali Zeaiter; Walter Bordogna; Bogdana Balas; Oscar Puig; Volkmar Henschel; Sai-Hong Ignatius Ou
Journal: Lancet Oncol Date: 2015-12-19 Impact factor: 41.316

3 in total